Peutz-Jeghers Syndrome and Jejunal Intussusception in Young Adults
Peutz-Jeghers syndrome (PJS) should absolutely be considered in this 19-year-old male with jejunal intussusception, as intussusception is the most common acute complication of PJS in young patients, occurring in 50% of cases by age 20 years. 1
What is Peutz-Jeghers Syndrome?
PJS is an autosomal dominant genetic disorder caused by germline mutations in the STK11/LKB1 gene, characterized by hamartomatous polyps throughout the gastrointestinal tract and distinctive mucocutaneous melanin pigmentation. 1
Key Diagnostic Features
The diagnosis can be established with any ONE of the following criteria: 1
- Hamartomatous polyp(s) PLUS at least 2 of: labial melanin deposits, family history of PJS, or small bowel polyposis 1
- Two or more PJS polyps 1
- Any number of PJS polyps with a family history of PJS in a close relative 1
- Characteristic mucocutaneous pigmentation with family history 1
Distinctive Clinical Characteristics
Mucocutaneous pigmentation (present in >95% of patients): 1
- Dark brown or blue-brown macules, 1-5 mm in size 1
- Located on vermilion border of lips (94%), buccal mucosa (66%), hands (74%), feet (62%) 1
- Critical pitfall: Pigmentation typically appears in infancy but fades in late adolescence and adulthood, so absence in a 19-year-old does NOT exclude PJS 1
- Unlike common freckles, PJS pigmentation crosses the vermilion border and appears on buccal mucosa 1
Hamartomatous polyps: 1
- Distinctive histology with branching smooth muscle extending into the polyp, arborizing pattern, cystic gland dilatation, and normal overlying epithelium 1
- Most commonly found in small bowel and colon 1
- Can appear anywhere in the GI tract except esophagus 2
Why This Matters for Your 19-Year-Old Patient
Intussusception is THE hallmark acute complication of PJS in young patients: 1
- Occurs in 15% of patients by age 10 years 1
- Occurs in 50% of patients by age 20 years 1
- Caused by hamartomatous polyps serving as lead points 3, 4
- Can be life-threatening, causing bleeding, obstruction, or bowel infarction 1
Critical diagnostic consideration: 4, 5
- Multiple intussusceptions can occur simultaneously in PJS patients 4, 5
- The entire small bowel must be examined intraoperatively to exclude additional intussusceptions 5
Immediate Clinical Actions
During surgical intervention for intussusception: 5
- Examine the ENTIRE small bowel for additional intussusceptions 5
- Send resected specimen for histopathology to identify hamartomatous polyp features 3
- Look for characteristic histologic features: hamartomatous architecture, arborizing smooth muscle, cystic glands 1
Post-operative evaluation to confirm PJS diagnosis: 1
- Perform detailed physical examination for mucocutaneous pigmentation on lips, buccal mucosa, hands, feet, perianal region 1
- Obtain detailed family history for PJS, early-onset cancers, or similar pigmentation 1
- Arrange genetic testing for STK11/LKB1 mutations (detected in 66-94% of PJS cases) 1
- Schedule upper and lower endoscopy to identify additional polyps throughout GI tract 3
Long-Term Cancer Surveillance Requirements
PJS patients face dramatically elevated cancer risks that mandate lifelong surveillance: 1
- Cumulative cancer risk: 1-2% by age 20, >30% by age 50, >80% by age 70 1
- Gastrointestinal cancers: Colorectal, pancreatic, stomach, small intestine 1
- Breast cancer: Significantly elevated risk requiring early screening 1
- Gynecologic cancers: Ovarian sex cord tumors with annular tubules (SCTAT), mucinous ovarian tumors, cervical adenocarcinoma 1
- Testicular tumors: Large-cell calcifying Sertoli cell tumors (LCCSCT) 1
Surveillance protocol starting immediately: 1
- Colonoscopy with polypectomy every 2 years 1
- Upper GI endoscopy every 1-3 years starting at age 18 1
- Annual pelvic examination and Pap test (for females) starting at ages 18-20 1
- Annual pelvic ultrasound (for females) 1
- Testicular examination for males 1
Genetic and Family Implications
Inheritance pattern: 6
- Autosomal dominant with variable penetrance 6
- 70% have positive family history, but 30% represent de novo mutations 6
- Critical pitfall: Absence of family history does NOT exclude PJS 6
Genetic testing recommendations: 1
- STK11/LKB1 mutation testing should be performed 1
- Detection rate is 66-94% even with modern techniques 1
- Negative genetic testing does NOT exclude clinical diagnosis of PJS 1
Epidemiology
Incidence: 1 in 50,000 to 1 in 200,000 live births 1, 6 Demographics: Affects all racial groups and both sexes equally 6 Average age at diagnosis: 23 years in males, 26 years in females 6